The Heart & Kidney Health Screening offers no-cost Lp(a) testing as well as screenings for other related metabolism and ...

Boston Scientific Corporation BSX recently announced favorable three-year primary endpoint data from the OPTION global ...

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help speed up the process of matching potential volunteers to relevant clinical ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...

While substantial progress has been made in sharing data from clinical trials, many top-selling medicines still fall short ...

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help ...

Jasper Therapeutics faces financial challenges but strong buy ratings. Read why JSPR stock is poised for growth amid risks ...

An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.

In a discussion with the Cobb Institute, Dr. Priscilla Pemu and Tesheia Harris shared insights on how to make clinical trials more inclusive.

The bidirectional research examines both laboratory findings and human clinical trial data, revealing that the medicinal use ...